Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
Date:4/29/2009

Conference Call and Webcast Scheduled for Wednesday, May 6, 2009

SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2009 financial results after the Nasdaq market closes on Tuesday, May 5, 2009. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday morning, May 6, 2009 at 8:30 a.m. Eastern Daylight Time (5:30 a.m. Pacific Daylight Time).

Participants can access the live conference call by dialing 1-800-895-0198, (US) or 785-424-1053 (International) using the conference ID: 7NEURO. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-688-7339 (US) or 402-220-1347 (International) using the conference ID: 7NEURO. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
2. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
3. Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets
4. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
5. Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t
6. Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
7. Pressure BioSciences, Inc. Provides Corporate Update
8. BIND Biosciences To Install First Siemens Simatic(R) PCS 7 Lab Process Control System in the U.S.
9. Cell Biosciences Announces First UK System Sale
10. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
11. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... relationship-marketing firm, honored finalists and winners Tuesday evening, May 3, at the 2016 ... Texas. , Scott Pettigrew, Vice President and Chief Security Officer of HMS, ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... With May flowers, summer is just around ... it means a welcome respite from school and the ability to play all day and ... for their children or watch the little tykes themselves. Summer also means trips to the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS Certification Institute, a ... new referral program, giving participants incentive for spreading the word about the Institute’s ... know many professionals share resources with their friends and colleagues,” said Vonda Andrews, ...
(Date:5/5/2016)... ... 2016 , ... Pigment Laser Tattoo Removal Center is proud to be the ... laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. This new laser ... the market. Jeremy Miller, Tattoo Artist and former reality show contestant on Spike ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... ctellez(at)msnva.org , The Medical Society of Northern Virginia, Announces DoctorsTelemed?, A ... The Medical Society of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
Breaking Medicine Technology: